Current Opinion in Pulmonary Medicine

Papers
(The TQCC of Current Opinion in Pulmonary Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective65
Drug-induced sarcoidosis-like reactions35
Drug-resistant tuberculosis: advances in diagnosis and management29
Activity-related dyspnea and exercise intolerance in chronic obstructive pulmonary disease: recent insights26
Advances in bronchoscopic optical coherence tomography and confocal laser endomicroscopy in pulmonary diseases25
A clinical review of long-COVID with a focus on the respiratory system24
Home monitoring in asthma: towards digital twins24
Sarcoidosis and maligancy: the chicken and the egg?22
Therapeutic bronchoscopy for malignant central airway obstruction: impact on quality of life and risk-benefit analysis22
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment22
Respiratory viral infections in the immunocompromised21
Current hot topics in pulmonary hypertension20
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis18
Big data in sarcoidosis18
Hit-hard and early versus step-up treatment in severe sarcoidosis17
The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases17
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis17
Labelling and denominating lung toxicity effects of pesticides16
Obesity-related asthma: new insights leading to a different approach16
Robotic bronchoscopy for peripheral pulmonary lesions: a convergence of technologies16
Thoracic computed tomography in the progressive fibrotic phenotype16
Bacteriophages for bronchiectasis: treatment of the future?16
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano16
Keeping global focus on the many challenges of respiratory tract infections15
Gram-negative pulmonary infections – advances in epidemiology and diagnosis14
Organ involvement and assessment in sarcoidosis14
Patterns of progression in non-IPF fibrotic interstitial lung disease14
Update on the genetic basis of obstructive sleep apnoea – hype or hope?13
Editorial introductions13
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown12
Editorial: COPD in the COVID-19 era, challenging concepts and developments in COPD, and occupational exposures and susceptibilities12
Epidemiology and real-life experience in progressive pulmonary fibrosis12
Bronchoscopic interventions for chronic bronchitis12
Senescence in pulmonary arterial hypertension: is there a link?12
Bronchoscopic treatment of early-stage peripheral lung cancer11
Editorial: Are we ready for prime time?11
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease11
Selected updates on chronic obstructive pulmonary disease11
Editorial: Pesticides and lung function11
The persistent problem of persistent air-leaks: approach to management11
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis11
Editorial introductions11
Drug treatment of COVID-19 infection11
Evidence from recent clinical trials in fibrotic interstitial lung diseases10
Outcomes of lung transplantation in cystic fibrosis10
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators10
Interstitial lung disease following coronavirus disease 20199
Effectiveness and safety of coronavirus disease 2019 vaccines9
Exhaled breath analysis in interstitial lung disease9
Novel insights in fibrotic pulmonary sarcoidosis9
The evolving role of radiological imaging in cystic fibrosis9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort9
Treatment strategies for malignant pulmonary nodule: beyond lobectomy. Point-counterpoint9
Thoracic empyema: aetiology, diagnosis, treatment, and prevention9
The role of PET in the management of sarcoidosis9
Digital outcome measures in pulmonary clinical trials8
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease8
Sarcoidosis associated pulmonary hypertension: an update8
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis8
Management of pneumothorax: an update8
COVID-19 and other respiratory tract infections at mass gathering religious and sporting events8
Syndromic genetic causes of pulmonary fibrosis8
Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review8
An update on bronchopleural fistulae following cancer-related surgery7
Altered pharmacology and toxicology during ageing: implications for lung disease7
Nonpharmaceutical interventions for managing SARS-CoV-27
Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease7
Training in interventional pulmonology: a leap into the future7
Diagnosis of invasive respiratory mycoses in the immunocompromised host7
Editorial introductions7
Role of biomarkers in lung nodule evaluation7
Infection control in cystic fibrosis: evolving perspectives and challenges7
Chronic obstructive pulmonary disease and obstructive sleep apnoea overlap: co-existence, co-morbidity, or causality?7
Pediatric sarcoidosis with diagnostic and therapeutical insights6
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease6
Editorial: The role of ageing in pulmonary disease6
What is new in mediastinal staging?6
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future6
Editorial: COVID pandemic and Lung cancer: challenges lead to opportunities6
At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease6
The justification for the progressive fibrotic phenotype6
Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype6
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities6
Improving care in lung cancer surgery: a review of quality measures and evolving standards6
The evolving paradigm of precision medicine in lung cancer6
How do we expand the lung donor pool?6
Direct oral anticoagulant use in special populations6
Editorial introductions6
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”6
The lung way home: ready for home monitoring in lung diseases?6
0.16289305686951